Why these 4 ASX shares are ending the week with a BANG

Aconex Ltd (ASX:ACX) is one of four shares rocketing higher today. Here's why they have ended the week with a bang…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is on course to have a strong end to the week with a 0.5% gain to 5,702 points.

Four shares in particular have had an even better end to the week. Here's why they've rocketed higher today:

Aconex Ltd (ASX: ACX) shares have jumped almost 5% to $5.70 despite there being no news out of the software-as-a-service company. Although the company's shares are the most shorted on the ASX, I think it is a great investment option for investors at the current price. If Aconex delivers on its long-term growth forecast I expect there could be significant share price gains ahead.

BlueScope Steel Limited (ASX: BSL) shares are up 4% to $11.50 today. This means its shares have now provided a 14% return for shareholders since this time last week. The steel manufacturer's shares have been on a tear because of the release of its impressive preliminary half-year results on Monday. For the first-half of FY 2017 BlueScope expects to deliver a 160% jump in underlying EBIT to $600 million.

Paladin Energy Ltd (ASX: PDN) shares have rocketed higher by 25% to 12.2 cents thanks to increased optimism regarding uranium prices. Prices fell to 12-year lows in 2016 as oversupply and weak demand hit the market. But with one major producer committed to reducing its output and demand likely to increase in Japan, uranium prices could be set to climb higher.

Zelda Therapeutics Ltd (ASX: ZLD) shares have been on fire today and climbed 11.5% to 2.9 cents despite there being no news out of the medicinal cannabis company. Although at this stage it may be a little on the speculative side, I believe Zelda could have a bright future. The company recently announced that it aims to use its cannabinoid formulations for the treatment of pancreatic cancer.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of ACONEX FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »